Donald Trump
Supreme Court rejects Trump’s bid to send National Guard to Chicago
The Supreme Court on Tuesday dealt a rare blow to President Donald Trump by rejecting his bid to overrule a lower court order and allow the deployment of National Guard troops to the Chicago area over the objections of local and state leaders. The Trump administration asked the Supreme Court to intervene in the case […]
Read More
Fed chair candidate Hassett says U.S. is way behind the curve on lowering interest rates
National Economic Council Director Kevin Hassett said Tuesday that the Federal Reserve is not cutting interest rates quickly enough, even though the U.S. economy grew at a much faster-than-expected pace in the third quarter. Hassett, a leading contender to succeed Federal Reserve Chair Jerome Powell when his term ends in May, said the artificial intelligence […]
Read More
Southwest’s profits are down 42% this year but it’s the top U.S. airline stock
A Southwest Airlines Boeing 737 airplane arrives at Los Angeles International Airport from San Francisco on March 28, 2025 in Los Angeles, California. Kevin Carter | Getty Images News | Getty Images Southwest Airlines‘ profits fell 42% in the first nine months of the year compared with the same period in 2024. But its stock […]
Read More
U.S. pushes additional tariffs on Chinese chips to June 2027
A silicon wafer with chips etched into is seen as U.S. Vice President Kamala Harris tours a site where Applied Materials plans to build a research facility, in Sunnyvale, California, U.S., May 22, 2023. Pool | Reuters The U.S. will increase tariffs on Chinese semiconductor imports in June 2027, at a rate to be determined at […]
Read More
Stocks making the biggest moves midday: Novo Nordisk, ServiceNow, Freeport-McMoRan, Structure Therapeutics & more
Check out the companies making headlines in midday trading. ServiceNow — Shares of the software company fell nearly 3% after it said it would acquire cybersecurity startup Armis for $7.75 billion . The deal, which should close next year, will bolster ServiceNow’s cybersecurity offerings. Mining stocks — With prices of gold, silver and copper at […]
Read More
Why we put Alphabet back in the Bullpen — plus, Cramer’s case for Nvidia in 2026
Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Tuesday’s key moments. 1. Stocks were little changed as bond yields rose after a strong third-quarter GDP reading dampened expectations for future Fed interest rate cuts. However, Jim Cramer said the market is […]
Read More
Epstein files: Latest batch from DOJ includes court records, flight logs and heavily redacted documents
The Department of Justice on Tuesday released another batch of files related to deceased sex offender Jeffrey Epstein. The latest documents appear to contain court records, emails, and some heavily or completely redacted files. In a Tuesday morning post to X, the DOJ announced the latest drop and claimed to have released “nearly 30,000 more […]
Read More
Novo Nordisk’s new obesity pill, Alphabet’s data center deal, the end of EV euphoria and more in Morning Squawk
The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, on the outskirts of Copenhagen, Denmark, Nov. 24, 2025. Tom Little | Reuters This is CNBC’s Morning Squawk newsletter. Subscribe here to receive future editions in your inbox. Here are five key things investors need to know to start the trading […]
Read More
EV realism is here. How automakers react in 2026 will be telling
Frederic J. Brown | Afp | Getty Images DETROIT – The U.S. automotive industry has entered a new phase for all-electric vehicles: realism. The industry was euphoric about the EV segment in the early 2020s, but consumer demand never took off as much as expected and, as it fizzled, automakers monitored and planned how to […]
Read More
Shares in Wegovy-maker Novo Nordisk pop 6% after GLP-1 pill approval
Shares in Novo Nordisk surged 6% Monday, after the Wegovy maker secured approval of its GLP-1 pill — a world first. The U.S. Food and Drug Administration’s approval of Novo Nordisk’s GLP-1 pill gives the Danish pharmaceutical giant a head start over U.S. rival Eli Lilly. The pill’s starting dose of 1.5 milligrams will be […]
Read More